As of August 15, 2014, the medication Namenda will be changing and be discontinued as it currently exists. Namenda (which is also called memantine or Ebixa)is used for the treatment of moderate to severe Alzheimer’s disease. The discontinuation is occurring because the company decided to move its focus to another version of the medication called Namenda XR. This medication serves the same purpose but may be more convenient because it only requires one dosage daily. Namenda XR is also available in an extended release tablet that can be opened and sprinkled on food for those who have difficulty swallowing pills. If you or a loved one is currently taking Namenda we urge you to discuss this change with the doctor. Overall, the switch to Namenda XR is expected to be helpful in making dosing easier, which is important for helping those with dementia.
Further information about this change can be found at Alzheimer’s & Dementia weekly: http://www.alzheimersweekly.com/2014/02/namendas-switch-to-namenda-xr.html?m=1